• Top in cardiology: Sacubitril/valsartan, refined grain consumption

    5 days ago - By Healio

    The FDA has granted an expanded indication for sacubitril/valsartan in adult patients with chronic heart failure, according to the manufacturer. The announcement was the top story in cardiology last week.
    Another top story was about new data from an international study that showed refined grain consumption was associated with an increased risk for mortality and cardiovascular events.
    Read these and more top stories in cardiology below:
    Sacubitril/valsartan receives expanded indication, including for some with HFpEF
    Novartis announced the FDA has granted an expanded indication for
    Read more ...